Back to search

University of Leeds

Improving organs for transplantation

Abstract

dc:description.abstract

Transplantation has grown exponentially with 4,533 life-saving UK transplants in 2022-23. Static cold storage (SCS), using University of Wisconsin solution (UW) is the gold standard. Despite increasing transplants, demand outstrips supply necessitating use of marginal organs. Here a novel preservation solution, Leeds solution for abdomen (LS-A) is examined, with SCS and Hypothermic oxygenated machine perfusion (HOPE) applications. A battery of biomarkers: HMBG-1 marker of necrosis; caspase-3 marker of apoptosis; syndecan-1 marker of glycocalyx function and Flavin mitochondrial mononucleotide (FMN) a putative marker of post-transplant function were examined. This was a pre-clinical, prospective, randomised controlled trial in a porcine model. Normothermic machine perfusion (NMP) simulated the post-transplant milieu. Livers were assigned to LS-A SCS or control (UW or IGL-1). A proof of principle comparison compared LS-A for both SCS and as a HOPE perfusate with UW for SCS and UW-MPS (UW Machine Perfusion Solution) for HOPE. Livers were interrogated for perfusate blood gases, biochemistry and histology. 50% of SCS LS-A livers met NMP viability criteria versus 0% of controls. LS-A shows significantly lower lactate and potassium. LS-A at 8-hours shows no significant differences from UW at 4-hours. When used for HOPE 40% of LS-A livers met viability criteria whilst no controls did. LS-A and UW-MPS showed no significant differences in lactate, but significantly lower potassium was seen in LS-A HOPE. There were significantly higher levels of apoptosis and necrosis with UW than LS-A in SCS but, no difference in HOPE. FMN showed no correlation with outcome. This study is the first to show LS-A performed better than UW in marginal organs. No difference existed between LS-A 8-hours versus UW 4-hours SCS. No significant difference exists between LS-A and UW-MPS in HOPE. FMN cannot predict viability, with no correlation between its pre-NMP levels and outcomes. LS-A provides exciting opportunities to improve organ preservation and live animal trials should follow.

Degree

thesis:*
Name dc:type.qualificationname
M.D
Level dc:type.qualificationlevel
doctoral
Grantor dc:publisher.institution
University of Leeds
Year dc:date.issued
2024

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Williams, Paul John
Advisors dc:contributor.advisor
  • Lodge, Peter
  • Quyn, Aaron
  • Laslo, Peter

Rights

Language dc:language.dcterms_iso639_2
eng

Identifiers

dc:identifier.*
Dc Identifier Grantnumber
a2001800

Chain of custody

source
Harvested from
White Rose University Consortium
Base URL
etheses.whiterose.ac.uk/cgi/oai2
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
related terms
citation

Williams, Paul John. Improving organs for transplantation. doctoral thesis, University of Leeds, 2024.